Dyadic International Inc (DYAI)
1.495
+0.06
(+4.55%)
USD |
NASDAQ |
May 06, 13:39
Dyadic International Cash and Short Term Investments (Quarterly): 7.263M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.263M |
| September 30, 2023 | 8.176M |
| June 30, 2023 | 10.13M |
| March 31, 2023 | 11.74M |
| December 31, 2022 | 12.64M |
| September 30, 2022 | 14.20M |
| June 30, 2022 | 15.64M |
| March 31, 2022 | 15.44M |
| December 31, 2021 | 20.26M |
| September 30, 2021 | 22.75M |
| June 30, 2021 | 25.60M |
| March 31, 2021 | 27.23M |
| December 31, 2020 | 29.09M |
| September 30, 2020 | 30.41M |
| June 30, 2020 | 31.83M |
| March 31, 2020 | 31.28M |
| December 31, 2019 | 34.22M |
| September 30, 2019 | 35.46M |
| June 30, 2019 | 36.89M |
| March 31, 2019 | 39.75M |
| Date | Value |
|---|---|
| December 31, 2018 | 41.20M |
| September 30, 2018 | 42.52M |
| June 30, 2018 | 44.33M |
| March 31, 2018 | 46.79M |
| December 31, 2017 | 47.69M |
| September 30, 2017 | 48.29M |
| June 30, 2017 | 40.78M |
| March 31, 2017 | 43.29M |
| December 31, 2016 | 48.94M |
| September 30, 2016 | 49.94M |
| June 30, 2016 | 51.95M |
| March 31, 2016 | 62.59M |
| December 31, 2015 | 68.60M |
| September 30, 2015 | 6.316M |
| December 31, 2014 | 2.496M |
| March 31, 2014 | 7.006M |
| December 31, 2013 | 8.892M |
| September 30, 2013 | 8.496M |
| June 30, 2013 | 7.048M |
| March 31, 2013 | 4.112M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
7.263M
Minimum
Dec 2023
36.89M
Maximum
Jun 2019
22.12M
Average
22.75M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 9.238M |
| Protalix BioTherapeutics Inc | 44.56M |
| Electromed Inc | 10.43M |
| Armata Pharmaceuticals Inc | 13.52M |